Cargando…

Significance and Therapeutic Value of miRNAs in Embryonal Neural Tumors

Embryonal tumors of the nervous system are the leading cause of childhood cancer-related morbidity and mortality. Medulloblastoma, supratentorial primitive neuroectodermal tumors, atypical teratoid/rhabdoid tumor and neuroblastoma account for more than 20% of childhood malignancies and typify the cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shalaby, Tarek, Fiaschetti, Giulio, Baumgartner, Martin, Grotzer, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271640/ https://www.ncbi.nlm.nih.gov/pubmed/24806581 http://dx.doi.org/10.3390/molecules19055821

Ejemplares similares

MicroRNA Signatures as Biomarkers and Therapeutic Target for CNS Embryonal Tumors: The Pros and the Cons
por: Shalaby, Tarek, et al.
Publicado: (2014)

G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors
por: Shalaby, Tarek, et al.
Publicado: (2013)

NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
por: Fiaschetti, Giulio, et al.
Publicado: (2014)

Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies
por: Shalaby, Tarek, et al.
Publicado: (2015)

The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma
por: Santhana Kumar, Karthiga, et al.
Publicado: (2015)

Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma
por: Fiaschetti, G, et al.
Publicado: (2014)

Exploring the role of miRNAs in early chicken embryonic development and their significance
por: Liao, Liqin, et al.
Publicado: (2023)

Therapeutic Value of miRNAs in Coronary Artery Disease
por: Ali Sheikh, Md Sayed, et al.
Publicado: (2021)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
por: Otoukesh, Babak, et al.
Publicado: (2020)

miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
por: Kousar, Kousain, et al.
Publicado: (2022)

Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
por: Wong, Jun Sheng, et al.
Publicado: (2020)

No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People
por: Tian, Fei, et al.
Publicado: (2017)

Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment
por: Shinde, Sonali S., et al.
Publicado: (2023)

Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
por: GAMBARI, ROBERTO, et al.
Publicado: (2016)

Exosomal miRNAs in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2020)

miRNAs as Therapeutic Tools in Alzheimer’s Disease
por: Lee, Chang Youn, et al.
Publicado: (2021)

Role of Nano-miRNAs in Diagnostics and Therapeutics
por: Coradduzza, Donatella, et al.
Publicado: (2022)

Modes of action and diagnostic value of miRNAs in sepsis
por: Antonakos, Nikolaos, et al.
Publicado: (2022)

High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer
por: Yi, Minhan, et al.
Publicado: (2021)

The expression and significance of five types of miRNAs in breast cancer
por: Min, Weili, et al.
Publicado: (2014)

Diagnostic significance of circulating miRNAs in systemic lupus erythematosus
por: Zheng, Xiaolan, et al.
Publicado: (2019)

Little things with significant impact: miRNAs in hepatocellular carcinoma
por: Li, Jiehan, et al.
Publicado: (2023)

Significant role of some miRNAs as biomarkers for the degree of obesity
por: Gouda, Weaam, et al.
Publicado: (2023)

miRNA signature of schwannomas: Possible role(s) of “tumor suppressor” miRNAs in benign tumors
por: Erkan, Erdogan Pekcan, et al.
Publicado: (2011)

Exosomal miRNAs: Biological Properties and Therapeutic Potential
por: Hu, Guoku, et al.
Publicado: (2012)

Exosomal miRNAs as cancer biomarkers and therapeutic targets
por: Thind, Arron, et al.
Publicado: (2016)

Moving miRNAs to therapeutic targets in colorectal cancer
por: McGregor, Mark, et al.
Publicado: (2019)

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
por: Arrighetti, Noemi, et al.
Publicado: (2021)

Therapeutic Implications of miRNAs for Muscle-Wasting Conditions
por: Yedigaryan, Laura, et al.
Publicado: (2021)

miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
por: Chakrabortty, Atonu, et al.
Publicado: (2023)

Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
por: Ma, Ya-Min, et al.
Publicado: (2023)

miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics
por: Mc Cormack, Bárbara A., et al.
Publicado: (2021)

miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma
por: Zarrilli, Giovanni, et al.
Publicado: (2021)

The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation
por: Xu, Guiyu, et al.
Publicado: (2016)

The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis
por: Zhang, Xiaoyi, et al.
Publicado: (2018)

Clinical value of integrated‐signature miRNAs in esophageal cancer
por: Zhang, Heng‐Chao, et al.
Publicado: (2017)

Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment
por: Tao, Hua, et al.
Publicado: (2018)

Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles
por: Mondal, Deepankar, et al.
Publicado: (2023)

Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress
por: Ali Sheikh, Md Sayed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_psu8bmb04h7te015l9arcltuie